Physician profile
Pooja Gupta
NPI 1336330786
$1,533.48
in general payments reported to CMS, 2019-2025
22 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $77.37 · 2021: $47.91 · 2022: $114 · 2023: $228 · 2024: $373 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $346.09 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $247.79 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $122.48 | 2019-2020 | |
| Abbvie INC. | $110.13 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $104.00 | 2019-2025 | Gardasil 9, Gardasil |
| Pfizer INC. | $99.95 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.44 | 2020-2025 | |
| Allergan, INC. | $58.47 | 2019 | |
| Coopersurgical, INC. | $47.33 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $47.30 | 2019 | |
| Minerva Surgical, INC | $35.40 | 2025 | |
| Sumitomo Pharma America, INC. | $31.13 | 2024-2025 | Myfembree |
| Roche Diagnostics Corporation | $30.65 | 2019 | |
| Organon LLC | $29.34 | 2024 | |
| Becton, Dickinson and Company | $28.26 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $24.82 | 2022 | |
| Ascend Therapeutics US, LLC | $24.33 | 2022 | |
| Exeltis, USA INC. | $23.53 | 2025 | Slynd |
| Biogen, INC. | $21.65 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $16.54 | 2021 | |
| Covidien LP | $12.51 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.